TL;DR: F0621-0205 (CAS 851718-29-1) is a chemical compound with molecular formula C18H21N3O3S2 and molecular weight 391.10245 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
N-[4-[2-(2-methylpropanoyl)-3-thiophen-2-yl-3,4-dihydropyrazol-5-yl]phenyl]methanesulfonamide
Also Known As: F0621-0205, N-{4-[1-(2-methylpropanoyl)-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide, N-[4-[2-(2-methylpropanoyl)-3-thiophen-2-yl-3,4-dihydropyrazol-5-yl]phenyl]methanesulfonamide, N-(4-(1-isobutyryl-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)methanesulfonamide
| Molecular Formula | C18H21N3O3S2 |
| Molecular Weight | 391.10245 g/mol |
| XLogP | 2.4 |
| Topological Polar Surface Area (TPSA) | 115.0 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Exact Mass | 391.10245 Da |
| Heavy Atoms | 26 |
| Complexity | 649.0 |
| SMILES | CC(C)C(=O)N1C(CC(=N1)C2=CC=C(C=C2)NS(=O)(=O)C)C3=CC=CS3 |
| InChIKey | HOQXRZZCFFFHDY-UHFFFAOYSA-N |
The XLogP value of 2.4 suggests moderate lipophilicity, balancing water solubility and membrane permeability for F0621-0205. The TPSA of 115.0 Ų falls within the moderate polarity range, balancing permeability and solubility for F0621-0205. Following Lipinski's Rule of Five, F0621-0205 has 1 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of F0621-0205 is 851718-29-1.
The molecular formula of F0621-0205 is C18H21N3O3S2.
The molecular weight of F0621-0205 is 391.10245 g/mol.
You can request a quote for F0621-0205 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for F0621-0205 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 851718-29-1. Our professional technical team will respond with pricing and lead time.